Are there any flight restrictions after a subarachnoid (subarachnoid space) hemorrhage (SAH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Flight Restrictions After Subarachnoid Hemorrhage

Patients who have experienced a subarachnoid hemorrhage should avoid air travel for at least 4-6 weeks after the initial bleeding event to minimize the risk of rebleeding and neurological deterioration.

Understanding the Risks

Subarachnoid hemorrhage (SAH) represents a serious neurological emergency with significant mortality and morbidity risks. The primary concerns regarding air travel after SAH include:

  1. Risk of rebleeding:

    • The peak risk for rebleeding occurs within the first 24 hours (up to 15% risk) 1
    • Risk remains elevated at approximately 1-2% per day for the first month 1
    • Overall rebleeding risk is 20-30% in the first month after hemorrhage 1
  2. Physiological effects of air travel:

    • Cabin pressure changes (equivalent to 5,000-8,000 feet altitude)
    • Potential for hypoxemia
    • Stress and motion during flight

Timing Recommendations

For Treated Aneurysms:

  • If aneurysm is secured (by clipping or coiling):
    • Wait at least 4 weeks before flying
    • Ensure complete neurological recovery and stabilization
    • Consider longer waiting period for patients who experienced complications

For Untreated or Partially Treated Aneurysms:

  • If aneurysm is not completely secured:
    • Avoid air travel for at least 6 weeks 1
    • Consider delaying travel until complete treatment is possible
    • Higher risk of rebleeding requires more conservative approach

Special Considerations

Medical Transport by Air

  • Emergency air medical transfer of SAH patients appears to be safe when properly managed 2
  • Requires:
    • Adequate sedation
    • Strict blood pressure control
    • Medical monitoring throughout transport
    • Availability of emergency interventions

High-Risk Patients

Extra caution is warranted for:

  • Patients with severe SAH (high Hunt-Hess grade)
  • SAH with intracerebral hemorrhage
  • Vertebral artery dissecting aneurysms
  • Patients with incomplete aneurysm treatment

Pre-Flight Assessment

Before clearing a patient for air travel after SAH, ensure:

  • Complete aneurysm obliteration confirmed by imaging
  • Resolution of vasospasm risk (typically peaks 6-10 days after SAH) 1
  • Stable neurological status
  • Controlled blood pressure
  • No evidence of hydrocephalus requiring intervention

Practical Recommendations for Air Travel

If air travel is absolutely necessary after the recommended waiting period:

  • Maintain adequate hydration
  • Consider prophylactic blood pressure medication if prescribed
  • Avoid alcohol and caffeine during flight
  • Move/stretch legs periodically to prevent deep vein thrombosis
  • Consider supplemental oxygen for long flights (discuss with physician)
  • Ensure medical documentation and contact information for treating physicians

Conclusion

The restriction on air travel after SAH is primarily based on the natural history of rebleeding risk, which is highest in the first month. While there are no specific randomized controlled trials addressing this question directly, the recommendation to avoid air travel for 4-6 weeks aligns with the known pathophysiology of SAH and the general principle of avoiding situations that could increase rebleeding risk during this critical period.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.